Spotlight Therapeutics to advance cell-targeted in vivo CRISPR gene editing biologics March 23, 2022 No Comments
Ixaka expands IP portfolio to allow use of TNP gene delivery platform across multiple areas March 21, 2022 No Comments
Series A financing at Scenic Biotech to support immuno-oncology and rare inherited disease pipeline March 10, 2022 No Comments
Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells March 7, 2022 No Comments
RSS